Kerecis Omega3 MariGen is a fish-skin graft that is homologous to human skin and is used for tissue regeneration. Kerecis Omega3 MariGen is FDA indicated for multiple clinical applications.
Because there is no risk of a viral-disease transfer from Atlantic cod to humans, the fish skin needs only mild processing for medical use and maintains its natural structure and elements, including Omega3 fatty acids.
When grafted onto damaged human tissue such as a burn or a wound, the fish-skin graft recruits the body’s own cells, supporting the body’s own ability to regenerate. The fish skin is a natural microbial barrier.
The superior clinical and economical performance of Kerecis Omega3 MariGen has been demonstrated in two non-industry funded, double-blind, randomized clinical trials and in numerous other clinical studies.